Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Global burden and trends of norovirus-associated diseases from 1990 to 2021 an observational trend study

Bibliographic Data

ID22091065
AuthorsMenglan Zhu (0000-0002-6721-2230), Ziling Huang (0000-0002-2838-0397), Z D Huang (Chinese People's Liberation Army), Tongtong Liu (0009-0009-9145-4211), Changhong Wu (0009-0004-6016-1460), Chennan Wu, ZhiHan Shang (305 Hospital of People Liberation Army), Lulu Zhang (0000-0003-2191-0663, corresponding author)
Year2025
Volume12
Pages1483149-1483149
Publication date2025-01-07
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2024.1483149
PMID39839433
OpenAlexW4406129977
LanguageEN
References cited49

Background: Norovirus remains a significant viral cause of waterborne and foodborne gastroenteritis outbreaks and epidemics worldwide. The burden of norovirus extends across different income settings. Methods: Leveraging secondary data from the 2021 Global Burden of Diseases Study, our analysis spanned the period from 1990 to 2021 to assess the burden of norovirus-associated diseases (NADs). We utilized descriptive statistics to examine global mortality rates and disability-adjusted life years (DALYs). For trend analysis, we employed annual percentage change (EAPC) through linear regression and applied Joinpoint analysis to identify significant changes over time. A comprehensive age-period-cohort model evaluated the key mortality risk factors. Furthermore, a Bayesian age-period-cohort analysis was conducted to forecast trends up to 2035, providing valuable insights for policy formulation and resource allocation. Results: In 2021, the global age-standardized mortality rate (ASMR) for NADs was 1.62 per 100,000 population (95% UI: 0.35 to 2.91), while the age-standardized DALY rates (ASDR) was 79.02 years per 100,000 population (95% UI: 26.61 to 132.26). A downward trend was observed in most regions and countries, with EAPC of -4.29% (95% UI: -4.53 to -4.05) for ASMR and -4.40% (95% UI: -4.62 to -4.19) for ASDR from 1990 to 2021. Notably, children under 5 years old had considerably higher ASDR: 475.52 years (95% UI: 160.73 to 893.72) per 100,000 for males and 335.44 years (95% UI: 112.29 to 623.48) per 100,000 for females. Mortality risk from NADs escalated with age, with a peak of 69.27 (95% CI: 64.04 to 74.92) per 100,000 for the under-five age group, and 11.38 (95% CI: 10.59 to 12.22) per 100,000 for individuals over 95 years. Bayesian Age-Period Cohort projections indicate a continued decline in ASMR and ASDR through 2035. Discussion: Between 1990 and 2021, ASMR and ASDR for NADs significantly declined due to public health interventions, vaccination, and improved sanitation. However, norovirus remains highly contagious, especially among children and the older adult. Projections suggest a continued decrease in the burden of such diseases by 2035. To further reduce this burden, preventive measures like vaccination and infection control strategies are essential for high-risk populations, alongside ongoing research into norovirus epidemiology and transmission dynamics

Environmental health · Norovirus · Observational study · Outbreak · Pathology · Child Nutrition and Water Access · Medicine · Respiratory viral infections research · Viral gastroenteritis research and epidemiology · Virology

  • Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021

    Open Access•Michael Brauer, Gregory A Roth et al.•The Lancet•2024

  • Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021

    Open Access•Mohsen Naghavi, Kanyin Liane Ong et al.•The Lancet•2024

  • Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the Covid-19 pandemic

    Open Access•Austin E Schumacher, Hmwe Hmwe Kyu et al.•The Lancet•2024

  • Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (Dalys), and healthy life expectancy (Hale) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021

    Open Access•Alize J Ferrari, Damian Francesco Santomauro et al.•The Lancet•2024

  • The trends in incidence of primary liver cancer caused by specific etiologies

    Open Access•Zhenqiu Liu, Yanfeng Jiang et al.•Journal of Hepatology•2019

  • Global Burden and Trends of Norovirus-Associated Diseases From 1990 to 2019

    Open Access•Xiaobao Zhang, Can Chen et al.•Frontiers in Public Health•2022

  • Long-term trends in the burden of inflammatory bowel disease in China over three decades

    Open Access•Yang Zhang, Ambroise Mazal et al.•Frontiers in Public Health•2022

  • Global prevalence of norovirus gastroenteritis after emergence of the GII.4 Sydney 2012 variant

    Open Access•Pan Zhang, Cai Hao et al.•Frontiers in Public Health•2024

  • Trends in cervical cancer mortality in China from 1989 to 2018

    Open Access•Menghan Guo, Juan Xu et al.•BMC Public Health•2021

  • The Non-uniqueness Property of the Intrinsic Estimator in APC Models

    Open Access•Ben Pelzer, Manfred Te Grotenhuis et al.•Demography•2015

Citation velocityhistorical
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae